Patients and Doctors Push Back Against the Harsh Side Effects of Cancer Drugs "If the patients are not taking the drug, then it's not going to work" Feb 06, 2024
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer News, features, and commentary about cancer-related issues Feb 02, 2024
Camp Lejeune Water Contamination Tied to a Range of Cancers, CDC Study Says Health risks now more firmly established, but study falls short of being definitive Feb 01, 2024
Pushback on Rule for Surgical Lymph Node Sampling During Lung Resection Surgeons debate the right standard for lymph node dissection in lung cancer Jan 31, 2024
No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer News, features, and commentary about cancer-related issues Jan 26, 2024
How Can Cancer Risk Be Cut in Communities Exposed to Toxins? Group outlines plan to bring the latest testing and treatment to medically underserved minorities Jan 25, 2024
EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk Findings don't tell us to stop these drugs, researcher says, but should guide clinical decisions Jan 13, 2024
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA News, features, and commentary about cancer-related issues Jan 12, 2024
Hypofractionated Chemoradiation With Adaptive SABR Appeared Effective in NSCLC Dose of 70 Gy in 15 fractions showed favorable balance between safety and efficacy in small trial Jan 12, 2024
Cryobiopsy and Forceps Biopsy Go Head-to-Head for Diagnosing Lung Lesions When added to needle aspiration, one method yielded better samples for molecular testing in NSCLC Jan 09, 2024
Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras News, features, and commentary about cancer-related issues Jan 05, 2024
Futile Immunotherapy for Cancer Grows More Common Occurs most often at non-academic and low-volume centers Jan 04, 2024
Cancer Patients Face Frightening Delays in Treatment Approvals "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer News, features, and commentary about cancer-related issues Dec 28, 2023
Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRC News, features, and commentary about cancer-related issues Dec 21, 2023
Homelessness Tied to Worse Cancer Outcomes Among Veterans However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings Dec 21, 2023
Andre Braugher's Cancer Dx; Malignancies Rising in Younger Adults; Negative Trials News, features, and commentary about cancer-related issues Dec 14, 2023
Grappling With Our Deadliest Cancer Here are essential steps to improve lung cancer screening Dec 10, 2023
Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug News, features, and commentary about cancer-related issues Dec 07, 2023
Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
With an Old X-Ray, AI Can Detect High Risk of Lung Cancer in Never Smokers Tool could identify nonsmokers most likely to benefit from low-dose CT screening Nov 29, 2023
Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations Researchers suggest the drug is a promising option for this rare subgroup Nov 22, 2023
Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
FDA OKs New Option for Advanced ROS1-Positive Lung Cancer Drug achieved high response rates in TKI-naive and TKI-pretreated patients Nov 16, 2023
Lung Cancer Survival High at 20 Years With Screen-Detected Tumors After two decades, lung cancer-specific survival remained at 81% in I-ELCAP program Nov 07, 2023
Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S. Findings suggest patients with SCLC are not screened for LEMS, despite their association Nov 02, 2023
ACS: Millions More Should Get Lung Cancer Screening Notably, new recommendations say it doesn't matter when a person quit smoking Nov 01, 2023
The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer Roy Herbst, MD, PhD, leads a discussion on ADCs targeting TROP2, HER2, and HER3 Oct 30, 2023 video
New Options Challenge Standard Treatments in EGFR-Mutant NSCLC Amivantamab-based regimens improved oncologic outcomes, but with more side effects Oct 25, 2023
ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancer Adjuvant alectinib reduces disease-free survival hazard by 76% Oct 24, 2023
Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers Still some unanswered questions about benefit over other drug regimens, expert says Oct 24, 2023
Targeting KRAS in NSCLC: Recent Progress and New Approaches Roy Herbst, MD, PhD, leads a discussion on current and emerging treatments available Oct 23, 2023 video
New First-Line Standard for Lung Cancers With EGFR Exon 20 Insertions Adding amivantamab to chemotherapy improved PFS, induced more rapid and durable responses Oct 23, 2023
RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC Two randomized studies demonstrate significantly improved PFS against standard regimens Oct 22, 2023
Bi-Specific T-Cell Engager Active in Small-Cell Lung Cancer in Third Line and Beyond Tarlatamab achieves 40% overall response rate at the dose selected for continued evaluation Oct 22, 2023
Pembrolizumab Wins FDA Approval in Operable Lung Cancer Checkpoint inhibitor demonstrated significant survival improvement in perioperative setting Oct 17, 2023
Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout? News, features, and commentary about cancer-related issues Oct 13, 2023
New Lung Cancer Cases Are Higher in Younger Women vs Men And the higher incidence rates now extend to women ages 50 to 54 as well Oct 12, 2023
Combination Therapy Wins FDA Approval for BRAF-Mutated NSCLC Encorafenib plus binimetinib led to 75% ORR in untreated patients, 59% in treated patients Oct 12, 2023
Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Results Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation Oct 10, 2023
